J2786 Injection, reslizumab, 1mg
Also known as: reslizumab, cinqair
Injection of reslizumab (Cinqair), 1 milligram, a monoclonal antibody against interleukin-4 (IL-4) receptor alpha used for severe eosinophilic asthma.
In Plain Language
asthma controller medication; immune modulator
Clinical Context
Used for severe asthma with eosinophilic phenotype and for hypereosinophilic syndrome to reduce inflammatory mediators.
RVU Information
CPT J2786 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J2786?
CPT J2786 (Injection, reslizumab, 1mg) is a J Codes (Drugs) code. Injection of reslizumab (Cinqair), 1 milligram, a monoclonal antibody against interleukin-4 (IL-4) receptor alpha used for severe eosinophilic asthma.
How is J2786 administered?
CPT J2786 is administered by a healthcare provider, typically via injection or infusion. Used for severe asthma with eosinophilic phenotype and for hypereosinophilic syndrome to reduce inflammatory mediators. It is used by Pulmonology, Allergy & Immunology.
When is CPT J2786 used?
Used for severe asthma with eosinophilic phenotype and for hypereosinophilic syndrome to reduce inflammatory mediators.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.